Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
06/2006
06/01/2006WO2006030211A3 Acyclic sulphonamides
06/01/2006WO2006023866A3 Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
06/01/2006US20060116406 e.g. 4-(4-fluorophenyl)-7-({5-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]-1,3-thiazol-2yl}thio)-2H-chromen-2-one; 5-lipoxygenases inhibitor; anti-asthmatic, anti-allergic, anti-inflammatory, cytoprotective and anti-artherosclerotic agents; angina, cerebral spasm, nephritis, hepatitis
06/01/2006US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
06/01/2006US20060116361 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
06/01/2006US20060115540 administering (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide; treating urogenital disorders
06/01/2006DE102004056626A1 Substituierte Oxyguanidine Substituted oxyguanidines
06/01/2006CA2588048A1 Substituted oxyguanidines
06/01/2006CA2586443A1 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
05/2006
05/31/2006EP1662318A1 1,3-dihydro-1-oxo-2H-indene derivative
05/31/2006EP1661890A1 Ppar-activating compound and pharmaceutical composition containing same
05/31/2006EP1661569A1 Compounds effecting glucokinase
05/31/2006EP1661568A1 Compounds effecting Glucokinase
05/31/2006EP1661567A1 Compounds effecting Glucokinase
05/31/2006EP1661563A1 Compound effecting Glucokinase
05/31/2006EP1660493A1 Peptidyl heterocyclic ketone derivatives and preparation processes
05/31/2006EP1660492A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
05/31/2006EP1660491A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
05/31/2006EP1660481A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators
05/31/2006EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives
05/31/2006EP1660428A1 Ppar modulators
05/31/2006EP1660427A1 Substituted arylalkanoic acid derivative and use thereof
05/31/2006EP1420644B1 Substituted propargylamines
05/31/2006EP1343772B1 Thia- and oxazoles and their use as ppars activators
05/31/2006EP1318986B1 Process for preparation of 2-amino-6-(alkyl) amino-4,5,6,7-tetrahydrobenzothiazoles
05/31/2006EP1296967B1 Benzothiazolyl ppar-gamma modulators
05/31/2006EP1296931B1 Polyamine analogues as cytotoxic agents
05/31/2006EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/31/2006CN1780832A 5-phenylthiazole derivatives and their use as PI3 kinase inhibitors
05/31/2006CN1780619A Derivados de benzoxazol e benzotiazol substitu¿¼dos com (dialopropenil)fenilalquila pesticidas
05/31/2006CN1257886C Dehydroamino acids compounds
05/30/2006US7053221 Heteroatom-stabilized carbenes and precursors thereto as depolymerization catalysts
05/30/2006US7053110 Dietetics; osteoporosis; muscular disorders
05/30/2006US7053109 Aminediols for the treatment of Alzheimer's disease
05/30/2006US7053106 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/30/2006US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
05/30/2006US7053088 Vanilloid receptor ligands and their use in treatments
05/30/2006US7053069 Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives
05/26/2006WO2006054652A1 Amide compound
05/26/2006WO2006045088A3 Polymer-filler coupling additives
05/26/2006WO2006029179A3 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
05/26/2006CA2584619A1 Amide compound
05/25/2006US20060111408 Therapeutic benzothiazole compounds
05/25/2006US20060111406 Amide linker peroxisome proliferator activated receptor modulators
05/25/2006US20060111359 enzyme inhibitor for treating sleep disorders
05/25/2006US20060111353 2-Cyclohexyl-1-(4-methanesulfonyl-phenyl)-cyclopropanecarboxylic acid 5-chloro-thiazol-2-yl)-amide; antidiabetic agents; non-insulin dependent diabetes; disorders associated with GK dysfunction; an enhanced solubility profile; improved metabolic stability; increased insulin secretion
05/25/2006US20060111344 Arylethanolamine beta2-adrenoreceptor agonist compounds
05/25/2006US20060111336 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
05/25/2006US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases
05/24/2006EP1658288A1 2-amino-5-benzoylthiazole npy antagonists
05/24/2006EP1658285A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
05/24/2006EP1658273A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
05/24/2006EP1658263A1 Novel aminobenzophenone compounds
05/24/2006EP1658071A2 Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors
05/24/2006EP1658066A2 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
05/24/2006EP1551850B1 2" oxo-voruscharin and derivatives thereof
05/24/2006EP1539723B1 Novel use of benzothiazole derivatives
05/24/2006EP1501812A4 Pna monomer and precursor
05/24/2006EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors
05/24/2006EP1257271B1 Use of pramipexole for the treament of tobacco/nicotine addiction
05/24/2006DE10347386B4 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories
05/24/2006CN1777593A Acylaminothiazole derivatives, their preparation and their use as beta starchy peptide to produce inhibitor
05/24/2006CN1777589A Heteroarylcarbamoylbenzene derivative
05/24/2006CN1775763A Carboxyl acylamide compound and its preparing method and use
05/24/2006CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods
05/23/2006US7049460 Aromatic guanidine compound; antitumor agents; anticancer agents
05/23/2006US7049330 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
05/23/2006US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/23/2006US7049297 Indazole peptidomimetics as thrombin receptor antagonists
05/23/2006CA2291134C Method for the preparation of citalopram
05/18/2006WO2006051704A1 Imine compound
05/18/2006WO2006051662A1 Thiazole derivative
05/18/2006WO2006051489A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
05/18/2006WO2006050830A1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same
05/18/2006WO2006024389A3 Biphenyl thiazole carboxamides
05/18/2006WO2005077945A3 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106224 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates
05/18/2006US20060106075 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
05/18/2006US20060106074 Er-b-selective ligands
05/18/2006US20060106053 Therapy of adenocarcinoma of the colon and rectum
05/18/2006US20060106015 Novel use of benzothiazole derivatives
05/18/2006CA2587667A1 Imine compound
05/18/2006CA2585983A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
05/17/2006EP1656373A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists
05/17/2006EP1656360A1 Thiazoline derivatives as selective androgen receptor modulators (sarms)
05/17/2006EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase
05/17/2006EP1656139A1 Aryl dicarboxamides
05/17/2006EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
05/17/2006CN1774267A Amyloid-binding, metal-chelating agents
05/17/2006CN1774246A Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases
05/17/2006CN1772744A Synthesis of (-)-2-amino-6-propionamido tetrahydro benzothiazole
05/17/2006CN1771943A Novel method of treatment
05/17/2006CN1256324C Pyrrolidine derivatives as factor Xa inhibitors
05/16/2006US7045558 Method of making a high refractive index optical management coating and the coating
05/16/2006US7045540 Selective estrogen receptor modulators
05/16/2006US7045539 Therapeutic benzoxazole compounds
05/16/2006US7045532 ACE-2 modulating compounds and methods of use thereof
05/16/2006US7045518 Compounds for treatment of AIDS with enzyme inhibitors
05/16/2006CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors